Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,875 | 10 | 56.1% |
| Food and Beverage | $9,475 | 269 | 20.5% |
| Travel and Lodging | $5,918 | 17 | 12.8% |
| Consulting Fee | $4,223 | 2 | 9.1% |
| Education | $660.82 | 9 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $33,875 | 97 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,037 | 24 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $2,222 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,080 | 32 | $0 (2024) |
| Incyte Corporation | $762.60 | 18 | $0 (2024) |
| Lilly USA, LLC | $675.74 | 21 | $0 (2024) |
| GENZYME CORPORATION | $641.60 | 22 | $0 (2024) |
| UCB, Inc. | $385.90 | 11 | $0 (2024) |
| LEO Pharma Inc. | $350.68 | 9 | $0 (2024) |
| Allergan, Inc. | $289.23 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,933 | 149 | ABBVIE INC. ($32,144) |
| 2023 | $8,331 | 90 | E.R. Squibb & Sons, L.L.C. ($3,822) |
| 2022 | $1,545 | 49 | ABBVIE INC. ($597.69) |
| 2021 | $314.15 | 8 | AbbVie Inc. ($268.43) |
| 2020 | $204.23 | 2 | AbbVie Inc. ($204.23) |
| 2019 | $349.43 | 4 | Allergan Inc. ($182.54) |
| 2018 | $278.00 | 3 | Lilly USA, LLC ($98.33) |
| 2017 | $196.75 | 2 | Janssen Biotech, Inc. ($99.00) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.17 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Immunology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.08 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $12.90 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $57.73 | General |
| Category: Immunology | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.30 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND, EBGLYSS | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $661.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $58.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND, EBGLYSS | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Immunology | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.56 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $133.69 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,131 | 3,854 | $675,692 | $182,554 |
| 2022 | 25 | 2,362 | 4,422 | $771,829 | $202,813 |
| 2021 | 11 | 599 | 831 | $161,155 | $48,301 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 371 | 499 | $114,770 | $30,525 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 291 | $96,030 | $25,383 | 26.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 236 | 286 | $83,080 | $23,179 | 27.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 200 | 225 | $59,864 | $14,469 | 24.2% |
| 15789 | Chemical peel of deep layer of skin of face | Office | 2023 | 31 | 35 | $38,121 | $14,260 | 37.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 299 | 380 | $63,977 | $13,806 | 21.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 72 | 92 | $38,923 | $12,195 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $34,000 | $9,655 | 28.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 115 | 115 | $32,775 | $8,323 | 25.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 235 | 1,483 | $24,573 | $7,803 | 31.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 16 | $12,645 | $3,760 | 29.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 49 | 80 | $10,817 | $3,331 | 30.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 24 | $10,950 | $2,947 | 26.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 27 | 30 | $10,206 | $2,856 | 28.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 21 | $13,318 | $2,155 | 16.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 21 | $6,998 | $2,100 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 45 | $6,525 | $1,770 | 27.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 16 | 16 | $6,071 | $1,597 | 26.3% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 18 | 18 | $4,130 | $765.28 | 18.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 19 | $2,735 | $634.50 | 23.2% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $2,792 | $598.27 | 21.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 31 | $1,550 | $346.20 | 22.3% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 12 | 14 | $490.00 | $79.94 | 16.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 22 | $352.00 | $16.78 | 4.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 348 | $114,840 | $31,505 | 27.4% |
About Dr. Ting-Lin Yang, MD
Dr. Ting-Lin Yang, MD is a Dermatology healthcare provider based in Bellingham, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2016. The National Provider Identifier (NPI) number assigned to this provider is 1154771954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ting-Lin Yang, MD has received a total of $46,151 in payments from pharmaceutical and medical device companies, with $34,933 received in 2024. These payments were reported across 307 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,875).
As a Medicare-enrolled provider, Yang has provided services to 5,092 Medicare beneficiaries, totaling 9,107 services with total Medicare billing of $433,668. Data is available for 3 years (2021–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Internal Medicine, Dermatology
- Location Bellingham, WA
- Active Since 06/13/2016
- Last Updated 10/10/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1154771954
Products in Payments
- SKYRIZI (Biological) $17,858
- RINVOQ (Biological) $15,582
- Sotyktu (Drug) $3,946
- DUPIXENT (Biological) $1,643
- OPZELURA (Drug) $646.59
- TALTZ (Drug) $518.81
- ADBRY (Biological) $325.68
- HUMIRA (Biological) $249.54
- Bimzelx (Biological) $234.57
- LIBTAYO (Biological) $231.40
- VTAMA (Drug) $231.35
- Zoryve (Drug) $201.95
- EUCRISA (Drug) $181.46
- ILUMYA (Biological) $181.40
- TREMFYA (Drug) $179.77
- KYBELLA (Biological) $178.97
- Otezla (Drug) $108.74
- STELARA (Biological) $99.00
- Tremfya (Drug) $98.28
- ONEXTON (Drug) $94.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Bellingham
Brian Hoyt, Md, MD
Dermatology — Payments: $1,513
Corinne Hecht, M.d, M.D
Dermatology — Payments: $924.91
Dr. Jan Dank, Md, MD
Dermatology — Payments: $902.81
Dr. Christina Lyons, M.d, M.D
Dermatology — Payments: $182.30
Mr. Richard Steinberg, Md, MD
Dermatology — Payments: $175.00
Dr. Stanley Gilbert, M.d, M.D
Dermatology — Payments: $118.55